RAHIMI KOSHKAKI, HASSAN
 Distribuzione geografica
Continente #
NA - Nord America 2.261
EU - Europa 992
AS - Asia 485
AF - Africa 60
SA - Sud America 35
Totale 3.833
Nazione #
US - Stati Uniti d'America 2.249
IT - Italia 537
SG - Singapore 194
SE - Svezia 168
IN - India 158
CN - Cina 85
FI - Finlandia 81
UA - Ucraina 57
DE - Germania 48
EG - Egitto 32
AR - Argentina 31
IE - Irlanda 25
ID - Indonesia 21
GB - Regno Unito 20
BG - Bulgaria 15
TG - Togo 14
FR - Francia 10
HK - Hong Kong 10
CA - Canada 9
ZA - Sudafrica 8
IR - Iran 6
RO - Romania 6
PL - Polonia 5
BE - Belgio 4
AT - Austria 3
CI - Costa d'Avorio 3
CO - Colombia 3
MX - Messico 3
NL - Olanda 3
RU - Federazione Russa 3
TW - Taiwan 3
DK - Danimarca 2
JP - Giappone 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MA - Marocco 2
NO - Norvegia 2
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
KR - Corea 1
PK - Pakistan 1
PT - Portogallo 1
SC - Seychelles 1
Totale 3.833
Città #
Fairfield 357
Rome 296
Chandler 180
Woodbridge 168
Ashburn 160
Seattle 143
Singapore 127
Cambridge 115
Houston 113
Wilmington 108
Ann Arbor 81
New York 65
Princeton 65
Plano 51
Beijing 39
San Paolo di Civitate 37
Helsinki 34
Boston 33
Dearborn 32
Lawrence 32
Damanhur 29
Millbury 26
San Diego 26
Dublin 25
Jacksonville 21
Jakarta 21
Santa Clara 21
Milan 20
Federal 19
Andover 16
Sofia 15
Boardman 14
Lomé 14
Norwalk 11
Bremen 10
Fremont 10
Hong Kong 10
Hyderabad 9
Indore 8
Falls Church 7
Toronto 7
Dallas 6
Munich 6
Phoenix 6
Putignano 6
Turin 6
Diano d'Alba 5
Grafing 5
Hefei 5
Palermo 5
San Isidro 5
Brussels 4
Johannesburg 4
Kunming 4
Leawood 4
Livorno 4
London 4
Redwood City 4
San Mateo 4
Shanghai 4
Abidjan 3
Avellino 3
Birmingham 3
Falkenstein 3
Germiston 3
Gunzenhausen 3
Los Angeles 3
Lucknow 3
Mexico City 3
Modena 3
Monte Grande 3
Nanjing 3
Portici 3
Somerville 3
Stockholm 3
Taipei 3
Wroclaw 3
Zhengzhou 3
Anguillara 2
Arzano 2
Bonn 2
Boulogne Sur Mer 2
Buenos Aires 2
Busto Arsizio 2
Cappelle sul Tavo 2
Chengdu 2
Chiavari 2
Colombo 2
Des Moines 2
Florence 2
Frankfurt am Main 2
Fuzhou 2
Guangzhou 2
Henderson 2
Ibague 2
Innsbruck 2
Kilburn 2
Kumar 2
Lappeenranta 2
Leeds 2
Totale 2.764
Nome #
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway 152
The macrophage Galactose-type C-type Lectin (MGL) modulates regulatory T cell functions 137
Bevacizumab-based chemotherapy triggers immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector t cell subsets 132
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial 117
Transplantation of stem/progenitor cells isolated from human fetal biliary tree into two patients with advanced liver cirrhosis 111
Anisakis pegreffii impacts differentiation and function of human dendritic cells 106
MGL receptor and immunity: when the ligand can make the difference 94
Tumor-derived microvesicles modulate antigen cross-processing via reactive oxygen species-mediated alkalinization of phagosomal compartment in dendritic cells 91
Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis. 89
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer. A meta-analysis 89
Immune effects of trastuzumab. 86
Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells 85
Past, present and future strategies of immunotherapy in gynecological malignancies 83
Production of interferon-γ by lymphocytes from paroxysmal nocturnal haemoglobinuria patients: Relationship with clinical status 81
Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing. 79
Anticorpi monoclonali contro la lipasi da Candida rugosa 78
Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region 78
Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer 76
Multiple Tumor Associated Peptide Vaccination As Consolidation Treatment In Women Affected by Breast and Ovarian Cancer 73
Human decay accelerating factor transgenic pigs for xenotransplantation obtained by sperm-mediated gene transfer 71
A comparative analysis of serum and serum-free media for generation of clinical grade DCs 70
Funzione immunoregolatoria dell'antigene tumore associato MUC1 durante l'ematopoiesi 69
null 64
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients 61
null 60
RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients 60
MGL lectin receptor and immunosuppression networks in glioblastoma 59
Regulated expression of MUC1 epithelial antigen in erythropoiesis 59
Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis 58
Immune response to the polymorphic epithelial mucin (PEM) 55
Monoclonal antibodies against Candida rugosa lipase 55
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells 54
T cell activation induced by MUC1 synthetic glycopeptides 51
Antimicrobial lipase antibody their nucleotide and aminoacid sequences and uses thereof 49
Investigating patterns of immune interaction in ovarian cancer: probing the O-glycoproteome by the macrophage galactose-like C-type Lectin (MGL) 49
Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation 49
Macrophage galactose-like lectin mediated interactions: investigating immunosuppressive mechanisms in glioblastoma 48
HER2-based recombinant immunogen to target DCs through Fc gamma Rs for cancer immunotherapy 47
Enhancement of Candida rugosa lipase activity by immunoglobulin light chain 47
Seasonal modulation of the C-type lectin MGL on human DCs 47
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells 46
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma 46
ANTIMICROBIAL LIPASE ANTIBODIES THEIR NUCLEOTIDE AND AMINOACID SEQUENCES AND USES THEREOF”. 45
Transfected human dendritic cells to induce antitumor immunity 45
null 45
Immunoglobulin light chain increases enzymatic activity of Candida rugosa lipase. 43
Generation and characterisation of monoclonal antibodies against lipases from Candida rugosa 43
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients 42
MUC1 expression in non lymphoid differential cell lineages from CD34+ cells 40
Engagement of MGL by the Tn-tumor glycoform of MUC1 induces DC signaling and activation 40
hDAF TRANSGENIC PIG GENERATION: A NEW SOURCE OF ORGANS FOR XENOTRANSPLANTATION 40
Polymeric nanoparticles decorated with monoclonal antibodies: a new immobilization strategy for increasing lipase activity 40
Isolation of MUC-1 primed B lymphocytes from tumour draining lymph nodes using immunomagnetic beads. 39
Enhancement of Candida rugosa lipase activity by immunoglobulin light chain 39
Proteomic characterization of extracellular vesicles released by third stage larvae of the zoonotic parasite anisakis pegreffii (Nematoda: Anisakidae) 34
MUC1 cross talk molecule during erythroid differentiation. 34
Immunomodulatory effects of radiofrequency tumor ablation in liver tumor patients. 33
Immunogenic cell death and immunomodulatory effects of cabozantinib 33
Dendritic cells for MUC1-based cancer immunotherapy 32
Immunoregulatory function of MUC1 tumor antigen during hematopoiesis 31
Soluble Immune checkpoints, gut metabolites and performance status as parameters of response to Nivolumab treatment in NSCLC patients 31
Immunomodulatory function of tumor antigen carrying vesiscles. 28
Immunomodulatory effects of radiofrequency tumor ablation in liver tumor patients 26
null 25
MUC1 tumor antigen as cross talk molecule during hematopoietic differentiation 24
Modulation of blood circulating immune cells by radiofrequency tumor ablation. 23
null 22
Circulating CD137+ T cell levels are correlated with response to Pembrolizumab treatment in advanced head and neck cancer patients 22
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs 20
Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma 10
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients 6
Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: systematic review and meta-analysis 5
IMMUNOGENICITY OF ALLO-VESICLE CARRYING ERBB2 TUMOR ANTIGEN FOR DENDRITIC CELL-BASED ANTI-TUMOR IMMUNOTHERAPY 1
Totale 4.052
Categoria #
all - tutte 12.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 326
selected - selezionate 0
volume - volumi 0
Totale 12.892


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020568 0 0 0 0 73 96 106 87 77 69 36 24
2020/2021363 33 31 26 28 39 24 8 30 43 60 28 13
2021/2022697 14 29 47 35 94 22 12 61 51 38 164 130
2022/2023755 146 140 42 74 76 64 11 61 63 15 31 32
2023/2024606 31 78 35 42 83 127 18 58 10 59 30 35
2024/2025268 41 52 80 69 26 0 0 0 0 0 0 0
Totale 4.052